Naples, FL, January 13, 2024 —NCH continues to lead the way in medical innovation, becoming the first healthcare provider in the state to offer the groundbreaking Van Gogh Biopsy tool from Aquyre Biosciences. This advanced technology redefines traditional biopsy procedures, providing results in as little as two minutes and eliminating the need for time-consuming traditional lab-based analysis.
The Van Gogh Biopsy technology is designed for use in assessing tissue during cancer diagnostics, and can rapidly identify cancer, immune and other cells. The tool leverages real-time optical imaging to evaluate tissue with exceptional precision, streamlining the diagnostic process and improving patient care. Unlike conventional methods that require tissue samples to be sent to a lab for analysis, the Van Gogh system provides instantaneous feedback, enabling physicians to make informed decisions on the spot.
“At NCH, we are committed to offering cutting-edge technology that enhances the patient experience,” said Paul Hiltz, President and CEO of NCH. “The Van Gogh Biopsy Tool aligns perfectly with our mission, allowing us to provide faster, more accurate diagnoses while reducing the stress and uncertainty for our patients.”
This innovative tool is particularly beneficial for patients undergoing evaluations for conditions where time is critical. By reducing the diagnostic process from days to mere minutes, the Van Gogh system empowers physicians to create immediate, tailored treatment plans.
The addition of the Van Gogh Biopsy Tool underscores NCH’s dedication to advancing healthcare quality and ensuring patients in Southwest Florida have access to the best and most efficient diagnostic tools available.
###
